HIGH RISK UNDIFFERENTIATED ACUTE LEUKEMIA

Clinical trials for HIGH RISK UNDIFFERENTIATED ACUTE LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new HIGH RISK UNDIFFERENTIATED ACUTE LEUKEMIA trials appear

Sign up with your email to follow new studies for HIGH RISK UNDIFFERENTIATED ACUTE LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Scientists test new drug combo to make risky cancer transplants safer

Disease control Completed

This study tested the safety of swapping out one drug (cyclophosphamide) for another (bendamustine) in the days following a bone marrow transplant. It involved 50 patients with various blood cancers who needed a transplant but lacked a perfectly matched donor. The goal was to see…

Matched conditions: HIGH RISK UNDIFFERENTIATED ACUTE LEUKEMIA

Phase: PHASE1 • Sponsor: University of Arizona • Aim: Disease control

Last updated Mar 23, 2026 15:14 UTC

HIGH RISK UNDIFFERENTIATED ACUTE LEUKEMIA

Get alerted when new HIGH RISK UNDIFFERENTIATED ACUTE LEUKEMIA trials appear

Scientists test new drug combo to make risky cancer transplants safer